TITLE

Deadly Radon in Montana? A Rebuttal To Dr. Larsson

AUTHOR(S)
Hart, John
PUB. DATE
April 2011
SOURCE
Dose-Response;2011, Vol. 9 Issue 2, p299
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
67699267

 

Related Articles

  • A Response to: Deadly Radon in Montana? Larsson, Laura S. // Dose-Response;2011, Vol. 9 Issue 2, p296 

    No abstract available.

  • Combatting the Crab.  // Time;10/9/1972, Vol. 100 Issue 15, p103 

    The article focuses on the chances of survival for cancer patients in the U.S. The National Cancer Conference of National Cancer Institute (NCI) and American Cancer Society reveals that chances of surviving cancer have raised wherein three out five patients can live for five years. It also cites...

  • Study: Spiral CT effective in detecting lung cancer. FORD, OMAR // Medical Device Daily;11/10/2010, Vol. 14 Issue 219, p1 

    The article offers information on the National Lung Screening Trial (NLST), a national trial of screening methods for reducing deaths from lung cancer through its detection at a relatively early stage. Results showed 20% fewer lung cancer deaths among patients screened with low-dose helical...

  • Deadly Radon in Montana? A Brief Note. Hart, John // Dose-Response;2011, Vol. 9 Issue 2, p293 

    No abstract available.

  • Deadly Radon in Montana? Puskin, Jerome S. // Dose-Response;2011, Vol. 9 Issue 3, p442 

    No abstract available.

  • Study Suggests Low-dose Radiation May Reduce Lung Cancer Deaths.  // 21st Century Science & Technology;2010, Vol. 23 Issue 3, p36 

    The article reports on a study by the National Cancer Institute (NCI) that suggests low-level radiation helps reduce lung cancer mortality in the U.S. It notes that the participants, which include 53,000 heavy smokers with a high risk for lung cancer, were randomly assigned to one of the two...

  • What Next? Orenstein, Beth W. // For the Record (Great Valley Publishing Company, Inc.);4/11/2011, Vol. 23 Issue 7, p24 

    The article reports on the findings of the clinical trial conducted by the U.S. National Cancer Institute's (NCI) National Lung Screening Trial (NLST) that show the benefits of computed tomography (CT) screening in reducing lung cancer mortality. It suggests that CT screenings for lung cancer...

  • Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I... Lippman, Scott M.; Lee, J. Jack; Karp, Daniel D.; Vokes, Everett E.; Benner, Steven E.; Goodman, Gary E.; Khuri, Fadlo R.; Marks, Randolph; Winn, Rodger J.; Fry, Willard; Graziano, Stephen L.; Gandara, David R.; Okawara, Gordon; Woodhouse, Charles L.; Williams, Brendell; Perez, Cherie; Kim, Hyung W.; Lotan, Reuben; Roth, Jack A. // JNCI: Journal of the National Cancer Institute;04/18/2001, Vol. 93 Issue 8, p605 

    Reports on the finding that retinoid chemoprevention may help to control second primary tumors (SPT), recurrence and mortality of stage I non-small-cell lung cancer (NSCLC) patients. Description of the Intergroup Phase III trial of the National Cancer Institute; Harm from isotretinoin in...

  • Surgery for early stage small cell lung cancer. Sartipy, Ulrik // Thorax;Oct2013, Vol. 68 Issue 10, p954 

    The article offers information on the study related to surgery for early stage small cell lung cancer sponsored by the U.S. National Cancer Institute.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics